What Happened?

Shares of medical lens company STAAR Surgical (NASDAQ: STAA) fell 3.5% in the afternoon session after the company announced a leadership transition, appointing interim co-CEOs following the recent resignation of its chief executive, which created uncertainty. 

The board appointed President and Chief Operating Officer Warren Foust and Chief Financial Officer Deborah Andrews to lead the company on an interim basis. This change followed the departure of CEO Stephen C. Farrell. The transition came during a turbulent period for the company, as investors had rejected a takeover deal just weeks prior to the CEO's resignation. The company's board has started a global search for a permanent chief executive to navigate its future.

The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy STAAR Surgical? Access our full analysis report here, it’s free.

What Is The Market Telling Us

STAAR Surgical’s shares are extremely volatile and have had 34 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.

The biggest move we wrote about over the last year was 6 months ago when the stock gained 45.6% on the news that eye-care company Alcon announced a definitive agreement to acquire the company in an all-cash deal valued at approximately $1.5 billion. Under the terms of the deal, Alcon paid $28 in cash for each share of STAAR Surgical. This price marked a 51% premium to the company's closing stock price on the previous day. STAAR Surgical manufactured implantable lenses for vision correction, including its EVO family of Implantable Collamer® Lenses. The acquisition allowed Alcon to absorb a key player in the ophthalmic surgery space.

STAAR Surgical is down 22.8% since the beginning of the year, and at $18.22 per share, it is trading 36.2% below its 52-week high of $28.57 from August 2025. Investors who bought $1,000 worth of STAAR Surgical’s shares 5 years ago would now be looking at an investment worth $166.27.

Do you want to know what moves the business you care about? Add them to your StockStory watchlist and every time a stock significantly moves, we provide you with a timely explanation straight to your inbox. It’s free and will only take you a second.